Implantable cardioverter-defibrillators: Expanding indications

Current Opinion in Cardiology

Volumn 19, Issue 4, 2004, Pages 317-322

  Naccarelli, Gerald V ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical trials; Implantable cardioverter defibrillator; Sudden death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; METOPROLOL; PROPAFENONE; SOTALOL;

CARDIOLOGY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; DISEASE COURSE; DRUG EFFICACY; EMPIRICISM; HEART ARREST; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HIGH RISK POPULATION; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MEDICAL SOCIETY; MORTALITY; PACEMAKER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SURVIVAL RATE; TACHYCARDIA; TREATMENT OUTCOME;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 3142768385     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000129666.57492.45     Document Type: Review

References (33)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
2. Kuck KH, Cappato R, Seibels J, et al.: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102:748-754.
3. Connolly SJ, Gent M, Roberts R, et al.: Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable defibrillator against amiodarone. Circulation 2000, 101:1297-1302.
4. Domanski MJ, Saksena S, Epstein AE, et al., for the AVID Investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999, 34:1090-1095.
5. Domanski MJ, Epstein AE, Hallstrom A, et al.: Survival of antiarrhythmic or implantable cardioverter-defibrillator patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias. J Cardiovasc Electrophysiol 2002, 13:580-583.
6. Anderson JL, Hallstrom AP, Epstein AE, et al., and the AVID Investigators: Design and results of the Antiarrhythmic Vs Implantable Defibrillators (AVID) registry. Circulation 1999, 99:1692-1699.
7. Wyse DG, Friedman PL, Brodsky MA, et al., for the AVID Investigators.: Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol 2001, 38:1718-1724.
8. Steinberg JS, Beckman K, Greene HL, et al.: Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. J Cardiovasc Electrophysiol 2001, 12:996-1001.
9. Gregoratos G, Abrams J, Epstein AE, et al.: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association/Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002, 106:2145-2161.
10. Naccarelli GV, Antzelevitch C: The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities. Am J Med 2001, 110:573-581.
11. Brugada J, Brugada R, Brugada P: Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death. J Electrocardiol 2001, 33:41-47.
12. Priori SG, Napolitano C, Gasparini M, et al.: Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002, 105:1342-1347.
13. Nademanee K, Veerakul G, Mower M, et al.: Defibrillator versus β-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial. Circulation 2003, 107:2221-2226.
14. Maron BJ, Shen W-K, Link MS, et al.: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000, 342:365-373.
15. DiMarco JP: Implantable cardioverter-defibrillators. N Engl J Med 2003, 349:1836-1847. Excellent, up-to-date review of ICDs and trials.
16. Knight BP, Goyal R, Pelosi R, et al.: Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999, 33:1964-1970.
17. Bigger JT, for the CABG Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997, 337:1569-1575.
18. Moss AJ, Hall WJ, Cannom DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933-1940.
19. Buxton AE, Lee KL, Fisher JD, et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999, 341:1882-1890.
20. Buxton AE, Lee KL, DiCarlo L, et al.: Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000, 342:1937-1945.
21. Moss AJ, Zareba W, Hall WJ, et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
22. Hohnloser SH, Connolly SJ, Kuck KH, et al.: The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol. Am Heart J 2000, 140:735-739.
23. Bansch D, Antz M, Boczor S, et al.: Primary prevention of sudden death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002, 105:1453-1458.
24. Strickberger SA, Hummel JD, Bartlett TG, et al.: Amioclarone Versus Implantable Cardioverter-Defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003, 41:1707-1712.
25. Kadish A, Quigg R, Schaechter A, et al.: Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 2000, 23:338-343.
26. Bardy GH, Lee KL, Mark DB, et al.: Sudden cardiac death in heart failure trial: pilot study. Pacing Clin Electrophysiol 1997, 20:1148.
27. The DAVID Trial Investigators: Dual chamber pacing or ventricular backup pacing for patients with an implantable defibrillator. JAMA 2002, 288:3115-3123.
28. Cazeau S, LeClercq C, Lavergne T, for the Multisite Stimulation in Cardiomyopathy Trial Investigators: Effects of biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 12:873-880,
29. Abraham WT, Fisher WG, Smith AL, et al., for the MIRACLE Investigators and Coordinators: Multicentre In-Synch Randomized Clinical Evaluation (MIRACLE): results of a randomized, double blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients. J Am Coll Cardiol 2001, 38:595-606.
30. Bristow MR, for the COMPANION Steering Committee and Clinical Investigators: Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing and Defibrillation in Chronic Heart Failure (COMPANION) trial. J Card Fail 2000, 6:276-285.
31. Cleland JG, Daubert C, Erdmann E, et al.: The Care-HF study (cardiac resynchronization heart failure study): rationale, design, and end-points. Eur J Heart Fail 2001, 3:481-489.
32. Prystowsky EN: Primary prevention of sudden cardiac death: the time of your life. Circulation 2004, 109:1073-1075. Recent editorial pointing out the pitfalls of subanalyses of trial data.
33. Linde C: Implantable cardioverter-defibrillator treatment and resynchronization in heart failure. Heart 2004, 90:231-234. Short, up-to-date review of ICDs and resynchronization therapy in heart failure.